+
Site Tour

EACTS 2021: EACTS/ESC MVR Guidelines update and implications: Introduction (Treatment Options for Secondary Mitral Regurgitation)

Hans-Joachim Schäfers
Introduction to symposium "Mitral Valve Replacement in the Current Era: New Guidelines and Considerations to Tailor the Treatment to Every Patient"

Related Videos

Review the Trends | Tricuspid focus

AV VALVES 2023: HoloLens Technology

Review the Trends | Mitral focus

AV Valves Summit 2024 | Closing of Day 1

PCRLV 2021: Transcatheter mitral valve replacement

ESC 2022: TEER Tutorial

PCR London Valves 2022 – Treatment of Mitral Valve disease

Navitor™: Voice of the Experts Lenard Conradi

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

Data Summary PFO closure in patients > 60 Years

EuroEcho 2021: MR Treatment (Patient)

PCRLV 2022: bRIGHT 1 year

PCRLV 2021: Transcatheter mitral valve replacement

CONNEXT


LIVE
RELATED EVENTS

PremiClose 2024: Neo-Ped Cardio Team

EACVI Summit 2023: Congress symposium

AV VALVES 2023: TA, TF in TMVR

TAVI Summit - TAVR in bicuspid

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline